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Paradoxical vocal fold motion disorder (PVFMD) is a laryngeal disorder that is typically 
triggered by vigorous exercise and primarily affects female athletes in their teenage 
years.  Previous research demonstrated that measures of inspiratory (Ri) and expiratory 
(Re) resistance reflect laryngeal constriction associated with PFVMD following exercise, 
but that baseline differences between PVFMD and normal function may also exist.  This 
study explored Ri and Re as measured by an Airflow Perturbation Device (APD) during 
resting tidal breathing (RTB) in 16 teenage female athletes with PVFMD and 16 healthy 
matched controls; half were 12-15 and half were 16-18 years old.  Ri and Re during RTB 
did not differ significantly between experimental and control groups nor between 
younger and older age groups.  These findings failed to replicate previous findings of 
baseline differences between groups and across age, although trends in the data suggest 
that sampling error may account for the difference in results.
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The respiratory system provides aerodynamic power to support phonation for 
speech, but its primary function is respiration.  During typical inspiration, the vocal folds 
are abducted to allow air to flow into the lungs.  During typical expiration, the vocal folds 
are also abducted but move in a slightly adductory direction as air flows out from the 
lungs.  In paradoxical vocal fold motion disorder (PVFMD), also known as vocal cord 
dysfunction, the vocal folds partially adduct during inspiration and sometimes remain 
partially adducted during expiration, thereby restricting the airway opening and impeding 
breathing (Matthers-Schmidt, 2001).  This laryngeal disorder can be triggered by 
vigorous exercise and primarily affects female athletes in their teenage years.  Since 
PVFMD affects breathing, an essential requirement for life, it has serious implications, 
and is within the scope of practice for diagnosis and treatment by speech-language 
pathologists (SLP; Matthers-Schmidt, 2001).  
The anatomy of the respiratory system includes the upper respiratory and lower 
respiratory tracts as well as the supporting structures of the chest wall.  The upper 
respiratory tract is composed of the nasal cavities, oral cavity, pharynx, and larynx.  The 
lower respiratory tract is composed of the trachea, bronchi, and lungs.  Resting 
inspiration is an active process that involves the diaphragm.  When the diaphragm 
contracts, lung volume increases.  Thus, the air pressure inside the lungs decreases 
relative to air pressure outside of the body, and air flows into the lungs allowing air 
pressure to equalize.  Resting expiration is accomplished passively via gravity, lung 
tissue recoil, and rib torque.  These passive processes result in decreasing lung volume, 




The impedance to airflow in the respiratory system results from resistances offered by the 
chest wall, lungs, bronchi, trachea, and larynx.  
 The inward and outward flow of air is the result of the physical properties of 
gases: flow, pressure, and resistance.  Aerodynamic evaluation of voice measures airflow 
with a pneumotachometer, and air pressure with a pressure transducer.  The 
pneumotachograph operates on the aerodynamic analog of Ohm’s law to effectively 
measure flow by determining the drop in pressure across a known resistance over time 
(Miller & Daniloff, 1993).  Once flow and pressure are determined, respiratory resistance 
can be calculated by dividing pressure (in cm H2O) by flow (in liters per second) at the 
airway opening (i.e., mouth).  Tools that introduce periodic perturbations to airflow 
during breathing can determine resistance by calculating modulations in pressure and 
flow during the perturbations.  Instruments based on this principle include whole-body 
plethysmography, impulse oscillometry, and a custom-designed device called the Airflow 
Perturbation Device (APD) (Haque et al., 2013).  The APD has been demonstrated to be 
feasible and valid for the assessment of inspiratory (Ri), expiratory (Re), and average 
respiratory (Rr) resistance during resting tidal breathing (RTB) as well as during a 
PVFMD episode (Gallena, Solomon, Johnson, Vossoughi, & Tian, 2015; Gallena, 
Solomon, Johnson, Vossoughi, & Tian, 2014; Haque et al., 2013; Johnson et al., 2007).   
This study aims to compare RTB in inspiratory and expiratory resistance values 
(i.e., Ri and Re) measured by the APD between young teenage girls (i.e., 12-14 years of 
age) and older teenage girls (i.e., 16-18 years of age) in good health, who deny 
experiencing exercise-related dyspnea.  Additionally, this study will investigate if teenage 




following sections of this thesis will initially provide a brief background on PVFMD and 
the population of people who are susceptible to this disorder.  Secondly, differences will 
be explored that may explain why teenage, female athletes are at risk for this disorder.  
Subsequently, conflicting evidence on who is at risk for this disorder will be addressed 
and discussed to show the need for this research.  A critical overview of how this disorder 
is diagnosed will then be explored by elucidating other ways to supplement physicians’, 
laryngologists’ and SLPs’ diagnosis with the use of the APD.  Finally, this review will 
highlight existing research that used this tool to assess PVFMD, and show future 
extensions on research to measure Ri and Re with this tool in the PVFMD population. 
PVFMD and Populations of Interest 
PVFMD can be triggered by vigorous exercise (Kayani & Shannon, 1998; 
Landwehr, Wood, & Milgrom, 1996; Mather-Schmidt, 2001; Rundell & Spiering, 2003; 
Sandage & Zelazny 2004).  This type of PVFMD is referred to as exercise-induced 
PVFMD, and typically affects athletes (Kayani & Shannon, 1998; Landwehr et al., 1996; 
Mather-Schmidt, 2001; Newman & Dubester, 1994; Rundell & Spiering, 2003; Sandage 
& Zelazny, 2004; Selner, Staudenmayer, Koepke, Harvey, & Christopher, 1987; Wood & 
Milgrom, 1996).  One study found that PVFMD occurred in 5% of 370 elite athletes, ages 
16-37 years, at one Olympic training facility (Rundell & Spiering, 2003).  Another study 
found similar evidence: 10% of athletes seen for dyspnea were later diagnosed with 
PVFMD (Maturo et al., 2011).  The types of activities that athletes with PVFMD engage 
include a range of sports: track, cross country, skiing, swimming, volleyball, softball, 
football, soccer, Tae Kwon Do, cheerleading, and basketball (Landwehr et al., 1996; 




sport activities among people with PVFMD already listed, but also included bobsledding, 
kayaking, badminton, figure skating, and biathlons.  Overall, aerobic activities seem to 
put athletes at risk for PVFMD.   
Studies show that PVFMD affects female athletes more than male athletes 
(Kayani & Shannon, 1998; Landwehr et al., 1996; Maturo et al., 2011; Newman & 
Dubester, 1994; Sandage & Zelazny, 2004).  Furthermore, teenagers, typically 11 to 15 
years of age, are diagnosed with PVFMD more than any other age group (Kayani & 
Shannon, 1998; Kuppersmith, Rosen, & Wiatrak, 1993; Landwehr et al., 1996; Powell et 
al., 2000; Sandage & Zelazny, 2004), although it may occur in older women as well 
(Newman & Dubester, 1994; Rundell & Spiering, 2003).   
Evidence on the etiology of PVFMD in teenage girls is sparse, but the most 
common trigger is exercise.  However, several additional triggers for PVFMD exist.  
Possible links with upper airway sensitivity to laryngeal irritants, laryngopharyngeal 
reflux (LPR), laryngeal dystonia, psychological factors, and neurological abnormalities 
have all been associated with PVFMD (Koufman & Block, 2008; Mathers-Schmidt, 
2001).  Competitive teenage athletes have very busy schedules, often have more than one 
activity in a day, and frequently report not eating a meal, eating late at night, or eating 
immediately before a competitive activity, which are all risk factors for LPR (Sandage & 
Zelazny, 2004).  Some studies have found an association with psychological disorders 
including sexual abuse, depression, and anxiety (Landwehr et al., 1996; Selner, et al., 
1987),  whereas other studies have found a psychological link to PVFMD unlikely 
(Christopher et al., 1983; Hayes, Nolan, Brennan, & Fitzgerald, 1993; Newman & 




for a disorder that is functional in nature (Koufman & Block, 2008; Mathers-Schmidt, 
2001).  Furthermore, the relationship between the changes in the larynx and what 
constitutes PVFMD should not be confused with other disorders that cause airway 
obstruction, such as laryngomalacia, papillomatosis, vocal fold paralysis, and laryngeal 
webbing (Sandage & Zelazny, 2004).   
Differences in the larynx between the sexes may explain why girls are more at 
risk for PVFMD.  Titze (1989) reported significant differences between the male and 
female larynx.  Specifically, Titze (1989) found that the larynx increases in size by 62% 
in boys between the ages of 10 and 16 years and by 34% in girls from 12-16 years.  
Additionally, vocal fold length increases to 16 mm on average in males and about 10 mm 
on average in females, and the thyroid cartilage is 20% larger in males versus females in 
both the angle of the thyroid and from its anterior to posterior dimension between the 
specified ages.  Thus, females have a smaller larynx and glottal area than males.  
Interestingly, the timing of these pubertal, laryngeal changes in girls matches evidence 
that PVFMD is most prevalent in girls from 11-15 years of age (Kayni & Shannon, 1998; 
Kuppersmith et al., 1993; Maturo et al. 2011).  Overall, physiological differences may 
interact in a way that puts girls, especially those in their early teens, at risk for PVFMD.  
Diagnosis of PVFMD 
 Differential diagnosis of PVFMD is difficult because it is commonly 
misdiagnosed as asthma (Brugman & Simons; Franca, 2014; Koufman & Block, 2008; 
Kuppersmith et al., 1993; Newman & Dubester, 1994; Sandage & Zelanzy, 2004).  While 
similar, these two disorders have distinct diagnostic criteria.  Asthma presents with chest 




longer onset (i.e., typically 5-10 minutes) and recovery period (i.e., 15-60 minutes to 
several weeks), and has a positive response to treatment with bronchodilators (Brugman 
& Simons, 1998; Mathers-Schmidt, 2001; Sandage & Zelazny, 2004).  Alternatively, 
PVFMD presents with throat tightness, stridor (i.e., audible breathing on inspiration), is 
triggered by exercise with a short onset (i.e., typically under 5 minutes) and recovery 
period (i.e., 5-10 minutes), and has a negative response to treatment with bronchodilators 
(Brugman & Simons; Mathers-Schmidt, 2001; Sandage & Zelazny, 2004).  Overall, both 
asthma and PVFMD affect both phases of respiration, but asthma is characterized 
primarily by audible expiration, whereas PVFMD is characterized primarily by audible 
inspiration.  However, misdiagnosis of PVFMD occurs and leads to inappropriate 
treatment with corticosteroids, intubation, and even tracheostomy in rare cases (Newman 
& Dubester, 1994).  Furthermore, asthma and PVFMD can co-occur, further 
complicating matters (Landwehr et al., 1996; Newman & Dubester, 1994).  One study 
found that an appropriate diagnosis of PVFMD was delayed by an average of four years 
because of misdiagnosis and unnecessary treatment (Maturo et al., 2011).  Therefore, 
proper techniques to diagnose this disorder are essential. 
To aid in differential diagnosis, authors have defined PVFMD’s diagnostic 
criteria to include inappropriate vocal fold adduction during inspiration, inability to 
abduct the vocal folds upon command, and the presence of a posterior glottal chink 
during a symptomatic episode (Koufman & Block, 2008; Landwehr et al., 1996; Newman 
& Dubester, 1994).  Given these laryngeal findings to diagnose PVFMD, this condition is 
typically diagnosed by a SLP and/or otolaryngologist with laryngoscopy (Matthers-




is not guaranteed because the occurrence of PVFMD is episodic and evidence of PVFMD 
may not be seen.  Moreover, this procedure cannot be tolerated by everyone because it 
involves insertion of a flexible laryngoscope through the nasal cavity, pharynx, and 
positioning its tip just above the vocal folds for examination.   
The APD could supplement laryngoscopy and could aid in evaluation of PVFMD.  
Lausted and Johnson (1999) invented the APD, a device that measures Ri, Re, and Rr 
using an airflow-perturbation technique.  During exercise, the airways offer even lower 
resistance than at rest because of efficient air exchange.  Efficient air exchange involves 
increased respiratory rate, greater air volume exchange, and a wider glottis during 
breathing (England & Bartlett, 1982).  This means that airway resistance is typically 
lower during aerobic exercise than during RTB in healthy individuals.  However, when a 
person with exercise-induced PVFMD is symptomatic, resistance is abnormally elevated 
because the glottis narrows, especially during inspiration.  The APD device is shown in 
Figure 1.  In brief, the APD provides a rotating wheel that offers periodic resistance 
modulation.  While breathing through a pneumotachometer, the periodic perturbations 
cause the airflow from the mouth to vary.  This affects the air pressure within the airways 
and the airflow at the airway opening.  Although the APD provides a measure of 
resistance across the entire respiratory system, specific changes at the level of the larynx 
can be detected.  This principle was demonstrated and validated by Gallena, Tian, 





Figure 1. - Schematic of the APD (left) and an athlete using the APD (right) (Reprinted with 
permission from Gallena et al., 2013). 
 
Haque et al. (2013) compared two devices that measured Ri and Re: the APD and 
whole-body plethysmography.  Whole-body plethysmography measures respiratory 
resistance indirectly using spirometric indices: forced expiratory volume (FEV) and peak 
expiratory flow (PEF).  Haque et al. (2013) found that the APD and plethysmography 
measures were highly correlated, but the APD was advantageous for two reasons.  First, 
the APD only requires spontaneous breathing (unlike plethysmography that requires 
trained breathing with the support of a respiratory therapist) and secondly, the APD is a 
portable device suitable for use outside a healthcare facility (unlike plethysmography 
which needs to be performed in a pulmonary-function lab).  Overall, Haque et al. (2013) 
showed that the APD has concurrent validity with other instruments that measure 
respiratory resistance.  
Physical characteristics such as age, height, weight, and sex can lead to variations 
in respiratory resistance values across individuals.  In a sample size of over 900 
participants from 2-88 years old, Ri and Re were higher in those who were shorter, 




have higher Ri and Re values than women, and women will have higher values than men.  
Additionally, Ri and Re decreased from 12 to 18 years of age with a steeper decrease 
beginning at 14 to 15 years of age.  This is consistent with research that showed that 
teenage girls from 11-15 years of age were typically diagnosed with PVFMD and that 
changes in the larynx occur at approximately the same time (Kayani & Shannon, 1998; 
Kuppersmith, et al., 1993; Landwehr et al., 1996; Powell et al., 2000; Sandage & 
Zelazny, 2004; Titze, 1989).  Given the findings from Johnson et al. (2007) on 
differences in Rr between young teenage girls and older teenage girls, future research 
should examine differences in Ri and Re between young teenage girls and older teenage 
girls.   
A limitation of the study by Johnson et al. (2007) is that it did not control for 
medical history, so it is unknown if the sample contained people with respiratory 
disorders such as PVFMD or asthma.  Therefore, future studies should control for 
respiratory disorders so that results can be generalized to normal or disordered 
populations. 
Respiratory Resistance and PVFMD  
 
Very little research on the quantitative assessment of PVFMD exists.  A series of 
investigations by Gallena et al. (2013, 2014, 2015) utilized the APD to determine 
respiratory resistance during inspiration and expiration.  Gallena et al. (2013) investigated 
the construct validity of the APD by demonstrating that measurements from the APD 
corresponded to concurrent changes in glottal area (GA).  Using simultaneous laryngeal 
imaging with laryngoscopy and resistance measurement by the APD with a participant in 




glottal area and respiratory resistance such that decreased glottal area was associated with 
increased respiratory resistance and vice versa.  
In a follow-up study, Gallena et al. (2014) investigated the test-retest reliability of 
the APD to measure respiratory resistance before exercise (RTB), after exercising (post-
exercise breathing, PEB), and after ~2-min of recovery from exercise (recovery 
breathing, RB) while seated.  Gallena et al. (2014) included 24 teenage female athletes: 
12 without PVFMD and 12 with PVFMD.  The study matched participants for sex, age, 
weight, and athletic performance.  An exercise challenge was introduced as a provocation 
activity to induce a PVFMD episode.  Additionally, reliability was examined within one 
session and across three sessions.  This supported data for test-retest reliability of the 
APD from Lausted and Johnson (1999) who found that inter-trial variability of 4-7% was 
acceptable and non-significant.  Results from Gallena et al. (2014) revealed strong test-
retest reliability for Ri and Re during RTB within one session for participants with and 
without PVFMD.  Due to ethical concerns over delaying treatment for PVFMD, 
participants with PVFMD could not be examined across sessions, but only across trials 
for one session.  The main effect across sessions was not significant for participants 
without PVFMD demonstrating that Ri and Re did not change and were reproducible 
within the same session (i.e., trials) and across sessions.  
Given good construct validity and reliability of the APD to measure Ri and Re in 
the PVFMD population, Gallena et al. (2015) compared the effect of exercise on the same 
participants with and without PVFMD during RTB and PEB (See Figure 2).  Measuring 
breathing before and after exercise in a seated position with the APD, respiratory 




resistance increased from RTB to PEB for participants with PVFMD (Gallena et al., 
2015).  Ri changed significantly between the two conditions for the PVFMD group, but 
did not differ significantly for the non-PVFMD group.  Overall, the APD was able to 
detect differences in respiratory resistance as a result of exercise that differentiated 
normal and disordered groups.  
It is important to note one unexpected finding.  Gallena et al. (2015) found that 
girls with PVFMD had lower Ri and Re than a control group during RTB, which suggests 
that even without a PVFMD episode there is a measurable difference between groups of 
participants with and without PVFMD.  A first step in investigating this result further is 
to replicate this finding in a new group of female athletes and to more carefully examine 
Ri and Re during RTB in girls across age, during the teenage years.   
 
 
Figure 2. Mean inspiratory (circles) and expiratory (squares) resistances for 12 athletes with (black) 
and 12 without (grey) PVFMD for resting tidal breathing (RTB), post-exercise breathing (PEB), and 







Summary and Statement of Problem   
 
The review of literature outlines some key points related to PVFMD.  If there is a 
constriction that impedes respiration due to adductory motion of the vocal folds, then 
flow is reduced and resistance is increased, consistent with a PVFMD episode that makes 
it difficult to breathe especially during inspiration.  Much of the evidence suggests that 
young teenage female athletes are at particular risk for PVFMD, but that the disorder also 
occurs in older teenagers (Kayani & Shannon, 1998; Kuppersmith et al., 1993; Landwehr 
et al., 1996; Maturo et al., 2011; Newman & Dubester, 1994; Powell et al., 2000; Rundell 
& Spiering, 2003; Sandage & Zelazny, 2004).  The APD has been shown to be a reliable 
tool to measure Ri and Re, and could possibly be used to supplement laryngological 
examination for the diagnosis of PVFMD (Gallena et al., 2013, 2014, 2015).  Studies 
have examined overall respiratory resistance across age as measured by the APD 
(Johnson et al., 2007), but not specifically related to changes in laryngeal resistance. 
What is currently known about inspiratory and expiratory resistances in people 
with PVFMD is based on a group of 12 teenage female athletes (Gallena et al., 2014, 
2015).  PVFMD can be triggered by exercise, causing laryngeal resistance to increase 
(Gallena et al., 2014, 2015; Kayani & Shannon, 1998; Landwehr et al., 1996; Mather-
Schmidt, 2001; Rundell & Spiering, 2003; Sandage & Zelazny, 2004).  An unexpected 
finding by Gallena et al. (2015) was that athletes with PVFMD demonstrated lower 
respiratory resistance values during RTB than teenage girls without PVFMD.  This 
finding is in stark contrast to higher than normal resistance values in participants during 




disordered, PVFMD, and non-disordered, non-PVFMD, female athletes across the 
teenage years.  This study addressed three research questions:  
1. Do female athletes with PVFMD have lower than normal respiratory resistance 
(Ri, Re) than age- and height-matched female athletes without PVFMD during 
RTB?  That is, can the incidental finding of lower Ri and Re by Gallena et al. 
(2015) be replicated with different participants?  
2. Do teenage girls with and without PVFMD show the age-related decrease in 
respiratory resistance reported by Johnson et al. (2007) for healthy teenagers?  
That is, are there similar differences in Ri and Re during RTB between younger 
(12-15 years old) and older teenage girls (16-18 years old) irrespective of 
PVFMD? 
3. Do Ri and Re during RTB differ more in teenage athletes with PVFMD than in 
teenage athletes without PVFMD as a function of age group?  That is, is there an 
interaction between diagnostic group and age group for respiratory resistance (Ri, 
Re)? 
The values of Ri and Re were compared between PVFMD and non-PVFMD groups, and 
each group had two age ranges, young (12-15years) and older (16-18 years) teenagers.  If 
it is true that participants with PVFMD have significantly lower resting respiratory 
resistance values (i.e., inspiration and/or expiration), then this could suggest that there are 
physiological differences in the laryngeal airway that can affect risk of PVFMD.  If Ri 
and Re do not differ significantly between participants with PVFMD and participants 
without PVFMD (contra Gallena et al., 2015), then it implies that respiratory resistance 




between individuals with and without PVFMD.  Conversely, it implies that individuals 
with PVFMD are heterogeneous in their laryngeal airway physiology during RTB.  
If Ri and Re differ significantly across age groups, then it shows that respiratory 
resistance changes with maturation, as demonstrated by Johnson et al. (2007).  
Furthermore, if Ri and Re differ significantly between younger and older teenage girls, 
then this indicates consistent maturational changes in respiratory resistance, expanding 
the findings of age-related differences in respiratory resistance by Johnson et al. (2007).  
If there is an interaction between group and age, then this could indicate the normal 
physiologic maturation pattern is not found or is accelerated in PVFMD.   
Methods 
Experimental Design  
This study used a between-groups experimental design.  The independent 
variables were diagnostic group (PVFMD, non-PVFMD) and age group (12-15, 16-18 
years), yielding four experimental groups.  The dependent variables were mean Ri and Re 
during resting breathing.  
Participants 
 This study included 16 participants with PVFMD and 16 without PVFMD.  Half 
of each group was between the ages of 12-15 years and the other half was 16-18 years 
old.  A power analysis, based on data from Gallena et al. (2015), indicated that a sample 
size of 8 for Ri and 12 for Re would be adequate to achieve power of 0.80 (two-tailed) 
with a Bonferroni corrected α value of 0.025.  Inclusionary criteria for both groups 
included aerobic activity at least two seasons out of the year and/or an average of aerobic 




the healthy controls included past and/or present conditions of asthma, allergies, 
respiratory disorders, voice disorders, neurological disorders, or cardiovascular disorders.  
Exclusionary criteria for the PVFMD group included a history of a respiratory or 
laryngeal disorder other than PVFMD, a neurological disorder, and/or cardiovascular 
disease.   
Participants without PFVMD were recruited from University of Maryland and the 
community (e.g., gyms, youth centers) using flyers, emails, and referrals from clinicians 
by the primary investigator (PI).  De-identified data of participants with PVFMD 
(different from those participants used in the original Gallena et al. (2015) study were 
obtained retrospectively from the Loyola Clinical Centers (LCC) in the Speech-
Language-Hearing Sciences Department at Loyola University Maryland because the 
facility diagnoses and treats patients with PVFMD. 
Healthy (non-PVFMD) participants were matched 1:1 to PVFMD participants for 
age (within 6 months) and height (within 7.62 cm).  An independent t-test was conducted 
to compare height and age in both groups.  There was no significant difference in the 
height of participants without PVFMD (M = 166.37 cm, SD = 7.16 cm) and participants 
with PVFMD (M = 166.62 cm, SD = 6.99 cm), t (16) = -0.13, p = .90.  There was no 
significant difference in age between participants with PVFMD (M = 15.6, SD=1.57) and 
participants without PVFMD (M=15.6, SD= 1.57), t (16) = 0.01, p = .99.  
Procedure 
          Consent and participant questionnaire 
Participants with PVFMD had previously consented to the use of their de-




University Maryland as part of standard protocol for PVFMD evaluation.  The diagnosis 
of PVFMD was established by an otolaryngologist and SLP.  Asthma was ruled out by a 
pulmonologist and allergies were ruled out or well controlled by an allergist.  Informed 
consent (and participant assent for those under 18 years of age) was obtained prior to any 
testing for the non-PVFMD group.  
Both groups, with and without PVMFD, filled out a similar questionnaire, which 
was based on a questionnaire used by Gallena et al. (2015) (Appendix A) to describe type 
and level of aerobic activity and medical history but was amended by the PI to query 
caffeine intake, exposure to second-hand smoke, history of playing a wind or brass 
instrument, and medical history.  Medical history included past and present conditions of 
asthma, allergies, respiratory disorders, voice disorders, neurological disorders, or 
cardiovascular disorders. Additionally, participants listed the weekly duration and 
intensity of physical activity, the level of play (e.g., junior varsity, varsity), and number 
of seasons they were involved in a sport.   
Data Collection  
Testing procedures for the non-PVFMD participants closely followed those used 
by Gallena et al. (2014, 2015) for the PVFMD participants obtained retrospectively for 
the current study.  Testing occurred in the Hearing and Speech Department at University 
of Maryland or a mutually agreeable public location that included gyms and recreation 
centers before engaging in exercise or more than 30 minutes after exercising.  All 
screening and procedures were administered in one session of about 30 minutes.  The 
equipment in the test room included use of the same chair for each participant.  The APD 




1. Seating the participant; 
2. Placing a disposable nose clip to eliminate nasal breathing;  
3. Placing a disposable filtered mouthpiece securely to the lips to ensure 
a good seal; 
4. Participants holding their cheeks to reduce movement that can distort 
resistance values; 
5. Placing their tongue below the mouthpiece to avoid airflow obstruction; 
6. Breathing into the device as naturally as possible via the mouthpiece for 
approximately one minute. 
Three acceptable trials that varied by no more than 10% were collected, each trial was 
separated by at least 10 seconds, and collected during a single session; breaks were 
provided as requested.  Participant instructions included: a description of the APD 
procedure, an illustration of an athlete correctly using the APD as a visual cue to perform 
the task correctly, and an explanation of the number of trials to be collected.  
Instrumentation 
The APD unit self-calibrated each time it was turned on for use.  During the 
course of data collection, the device did not pass calibration three times and required 
equipment maintenance and replacement by a qualified technician (i.e., the inventor of 
the device).  As a result, three different APDs were used to collect data.  A single device 
was used for the PVFMD group (N=16 with APD N25) and, after the repair, for the 
majority of the non-PVFMD group (N= 9 with APD N25).  The remaining data were 
collected with two other APDs (N=1 with APD N29, N=6 with APD N6).  To assess 




conducted on the experimenter’s values of Ri and Re during RTB before each data-
collection session.  Results varied by < 10% throughout the duration of the study.  
Furthermore, no device was used at any time that did not pass self-calibration.  A single 
examiner (SG) collected all PVFMD data and a second examiner (AP) collected all non-
PVFMD data after being trained by and deemed reliable with the first examiner.   
Each perturbation resulted in a pressure and flow measure used to calculate 
respiratory resistance (i.e., quotient of air pressure in cm H2O divided by airflow in liters 
per second (L/s)).  A trial consisted of approximately 1 minute of breathing or ~500 
perturbations of airflow by the wheel on the APD.  The mean resistances during the 
inspiratory (Ri) and expiratory (Re) phases of breathing were obtained for each participant 
per trial from a digital display on the APD.  The following measures are displayed on the 
APD screen, and were recorded manually by the tester: 
• Mean respiratory resistance (Rr) (in cm H2O/L/s)  
• Mean inspiratory resistance (Ri) (in cm H2O/L/s) 
• Mean expiratory resistance (Re) (in cm H2O/L/s) 
Statistical Analysis 
 Statistical analyses were performed with SPSS software (SPSS, International 
Business Machines, version 22, Chicago, Illinois) with a α value for significance set at 
.025.  A conservative α value was used in order to account for the two dependent 
variables of interest, Ri and Re.  The data met the requirement of homogeneity of variance 
for parametric statistical tests based on Mauchley’s Test of Sphericity or Levene’s Test of 




 Prior to averaging Ri and Re values across three trials, repeated-measures 
ANOVAs with trial as the within-subjects variable was used to determine the trial-to-trial 
stability of Ri and Re.  Participants were included in this analysis if they had complete 
data from all three trials (PVFMD, N= 11, non-PVFMD, N = 16).  There was no 
significant effect of trial for either group for Ri or Re (F < 3.3, p > .05 for all analyses), as 
summarized in Table 1.  Thus, average Ri and average Re were computed across trials and 
used in subsequent statistical analyses. 
 
Table 1 - Results of the repeated measures analysis of variance comparing Ri and Re across trials for 
each group 
Group    Dependent Variable       F Value                            P Value 
Non‐PVFMD																		 Ri			 F	(1,	15)	=	3.18													 .10	
	 Re	 F	(1,	15)	=	0.01	 .95	
PVFMD	 Ri			 F	(1,	10)	=	1.05													 .33	
	 Re	 F	(1,	10)	=	2.69													 .13	
  
 
Results   
 The respiratory resistance values for each diagnostic group and age group are 
reported in Table 2 and illustrated in Figures 3 and 4. Given that Ri and Re were strongly 
correlated (Pearson r = 0.92, p < 0.001), the effects of diagnostic group (PVFMD, non-
PVFMD) and age group (12-15, 16-18 years) were compared using a MANOVA with 
both Ri and Re as dependent variables.  There were no significant effects for diagnostic 
group (F (2, 27) = 1.72, p =.20, Wilk’s  = .89, partial 2 =.11) or age group (F (2, 27) 
= .94, p =.40, Wilk’s  = .94, partial 2 =.07), and no significant interaction between 







Table 2- Descriptive Statistics (M (SD)) for Ri and Re during RTB 




	 16‐18	(N=8)	 3.50 (0.99)	 4.08 (1.09)	




	 16‐18	(N=8)	 3.05 (0.54)	 3.34 (0.65)	




Figure 3 - Results of the between group analysis comparing diagnostic group and age group on Ri in 




























Figure 4 - Results of the between group analysis comparing diagnostic group and age group on Re in 
RTB with error bars indicating SD. 
 
 Individuals were matched closely across groups for age; therefore, optimizer 
statistics were conducted using one ANOVA with a covariate of age for Ri and a second 
ANOVA with a covariate of age for Re.  There was no significant effect of diagnostic 
group, but the difference in Ri and Re values between non-PVFMD and PVFMD groups 
trended toward significance (Ri: F (1,29) = 4.12 p =.052; Re: F (1,29) = 3.67, p =.065). 
Discussion 
 The present study examined respiratory resistance in female teenage athletes with 
PVFMD compared to individuals without PVMFD by measuring Ri and Re during RTB 
using an APD.  The purpose of the study was to determine if measures of Ri and Re could 
differentiate participants with PVFMD from healthy controls matched for sex, age, and 
height.  The findings indicated that, although there are differences in Ri and Re on average 
between the two groups in the expected direction, these differences did not meet the 



























differentiating the two diagnostic groups based on resting breathing measures alone.  The 
second goal of this study was to determine if respiratory resistance in athletes differed 
between younger and older teenage girls.  Although there were differences in Ri and Re 
on average between the two age groups such that Ri and Re values decrease with age, the 
differences were not statistically significant.  Based on these findings, it is unclear if there 
are maturational differences in teenage years that affect resting respiratory resistance.  
Additionally, there were no interactions between diagnostic group and age group.  These 
findings will be discussed in the following sections.   
 The first research question was designed to replicate the findings of Gallena et al. 
(2015) that Ri and Re were lower during RTB in female teenage athletes with PVFMD 
than in those without PVFMD.  A statistically significant difference between groups 
would have supported the hypothesis of physiologically different breathing patterns in 
participants with PVFMD, prior to changes that occur during physical exertion.  In this 
new group of teenagers, Ri and Re values were generally lower in the group of 
participants with PVFMD than those without PVFMD, but the differences did not meet 
criterion for statistical significance due to the large within-group variability (error bars in 
Figures 3 and 4).  When the analysis was repeated using age as a covariate and 
comparing the data between diagnostic groups, there was a trend toward significance for 
diagnostic group compared to the MANOVA with two between-subjects factors and 
without covariates, but was still not significant, when the α was Bonferroni-adjusted for 
multiple comparisons. 
 Gallena et al. (2015) proposed that differences in RTB between PVFMD and 




patterns as a result of PVFMD.  That is, respiration is regulated by central pattern 
generators that involve a feed-forward mechanism and chemoreceptor feedback system 
that regulates, senses, and adjusts respiration based on the level of carbon dioxide (CO2) 
and other factors in a complex system to maintain homeostasis (Mitchell & Babb, 2006).  
This shows that sensory input can drive motor aspects of respiration, due to the cyclic 
relationship between the feed-forward and chemoreceptor feedback system.  Mitchell and 
Babb (2006) proposed that this system is affected by exercise for within-trial alterations 
(i.e., one exercise session) called modulation and across-trial alterations (i.e., multiple 
exercise sessions) called plasticity that results in motor learning that affects all aspects of 
respiration (i.e., RTB, PEB, RB).  Moreover, Mitchell and Babb (2006) suggested neural 
adaptation can result in short-term or long-term changes in respiration and be influenced 
by physiological conditions associated with impaired pulmonary mechanics (for example 
PVFMD).  Although Ri and Re during RTB was not statistically significantly lower for 
the PVFMD than the non-PVFMD participants in the current study, some of these factors 
may have contributed to the trend in these data in the expected direction.   
 This study’s findings that Ri and Re  in RTB were not significantly different 
between participants with and without PVFMD may also be explained by gender 
differences in neural adaptation, given that females have decreased neural adaptation with 
exercise during hypoxic states (Mitchell & Babb, 2006).  Furthermore, hypoxia is 
affected by the terrain and altitude in which athletes perform (Czuba et al., 2011).  Since 
neural adaptation affects all aspects of respiration (i.e., RTB, PEB, RB), it is possible that 
this study included female participants that exercise in environments that cause hypoxia, 




study recruited participants from the same geographical area.  Thus, the role of hypoxia 
may be minimal given that athletes perform generally in the same exercise terrain and 
altitude.  The types of athletic activities that athletes with PVFMD engaged in included a 
range of sports involving aerobic activity (Landwehr et al., 1996; Rundell & Spiering, 
2003; Selner et al., 1987; Wood & Milgrom, 1996).  Gallena et al. (2015) and the current 
study included participants that engaged in a range of sports including: track, cross-
country, swimming, volleyball, field hockey, and soccer.  The variety of sports increases 
the likelihood of different terrain and exercise conditions.  However, participants were 
not matched on specific sports and the questionnaire did not include a question about the 
exercise environments, so these issues cannot be explored. 
 The second research question was designed to replicate the findings of Johnson et 
al. (2007) that Ri and Re during RTB decrease with age.  If Ri and Re differed significantly 
between younger and older teenage girls, then this would have further expanded Johnson 
et al.’s (2007) findings that children, teenagers, and adults represent different values of 
respiratory resistance.  Although there was an overall decreasing trend with age (Figures 
3 & 4), Ri and Re during RTB did not differ significantly between the two age groups 
irrespective of PVFMD, indicating that these measures should be considered similar for 
teenage girls as a single group.  
 Gallena et al. (2015) matched participants for sex, age, height, weight, and 
athletic performance.  This study matched for sex, age, height, and athletic performance, 
but participants were not matched for weight.  Johnson et al. (2007) found that weight 
was a significant factor in determining Rr, which is an average of Ri and Re.  Given the 




have reached statistical significance for group if participants were matched on age, 
height, and weight.   
 The third research question was to determine if age group interacted with 
diagnostic group when examining data for Ri and Re during RTB.  There was a trend of 
decreasing respiratory resistance values with increasing age in the absence of PVFMD.  
However, this trend was not statistically significant, as shown by the lack of a significant 
interaction between age group and PVFMD diagnosis.  These findings indicated that 
participants were similar enough that it may make it difficult to explore the compound 
effect of diagnostic group and age group on Ri and Re in RTB.  
 Since there was no significant difference between groups and no interaction 
between disorder group and age group, these findings fail to provide physiological 
evidence for the increased susceptibility of PVFMD in teenage girls, based upon RTB 
alone (Kayani & Shannon, 1998; Landwehr et al., 1996; Maturo et al., 2011; Newman & 
Dubester, 1994; Sandage & Zelazny, 2004).  An alternative explanation, as described 
previously, involves neural adaptation that could vary between males and females for a 
variety of factors (Mitchell & Babb, 2006).  It should also be noted that neural adaption is 
more robust with increased exercise (i.e., neural adaptation was not noted for one 
exercise session, but was for repeated exercise sessions) (Mitchell & Babb, 2006).  This 
might explain why PVFMD affects elite athletes who engage in vigorous exercise 
(Kayani & Shannon, 1998; Landwehr et al., 1996; Mather-Schmidt, 2001; Newman & 
Dubester, 1994; Rundell & Spiering, 2003; Sandage & Zelazny 2004; Selner et al., 1987; 




 An interesting finding by Mitchell and Babb (2006) regards the relationship 
between respiration, neural adaptation, and serotonin.  The relationship between 
respiration and puberty could explain why young teenage girls, typically 11 to 15 years of 
age, are diagnosed with PVFMD more than any other age group, and match laryngeal 
changes that occur in puberty between the ages of 12-16 years of age in girls (Kayani & 
Shannon, 1998; Kuppersmith et al., 1993; Landwehr et al., 1996; Powell et al., 2000; 
Sandage & Zelazny, 2004; Titze, 1989).  The onset and changes that occur during 
puberty are derived from a complex interplay between neuropeptides, neurotransmitters 
(e.g., serotonin), and neurosteroids observed in animal and human models (Genazzani, 
Bernardi, Monteleone, Luisi, & Luisi, 2000).  Furthermore, serotonin is linked with the 
reproductive cycle and hormonal events (Genazzani et. al., 2000).  Given the relationship 
between respiration and puberty that serotonin seems to play a role in mediating, this 
could explain the diagnosis of young teenage girls with PVFMD at the same time that 
pubertal changes are co-occurring.  
 To summarize, this study failed to find significant differences in RTB between 
diagnostic groups (PVFMD, non-PVFMD) or age groups (11-15, 16-18).  The possible 
reasons for this are large within-group variability in RTB values, not controlling for 
certain confounds (i.e., weight, sport, exercise environment), minor age differences 
between younger and older groups, tendency of smaller neural adaptation effects in 
females, and use of different APDs across participants.  Therefore, it may be that Ri and 
Re in RTB differ between diagnostic groups and across age groups, but that it was 





Limitations and Future Directions 
  The sample of participants in the study by Gallena et al. (2015) and this study 
were different.  It is difficult to state which sample group is more representative of the 
entire population of patients with PVFMD and, therefore, which results have more 
external validity in representation of true Ri and Re during RTB.  Although the present 
sample size was larger than Gallena et al.’s, it is possible that it was not large enough.  
However, based on data from Gallena et al. (2015), a sample size of 8 for Ri and 12 for Re 
should have been adequate to achieve power of 0.80 (two-tailed) with a Bonferroni 
corrected α value of .025.   
 Future studies should match for sex, age, height, weight, and sport to control for 
confounding factors based upon earlier research (Czuba et al., 2011; Gallena et al., 2015; 
Johnson et al., 2007; Mitchell & Babb, 2006).  Additionally, future studies should include 
a questionnaire on puberty, exercise terrain, and geographical area of sports activity.  
Given the results of some studies (Genazzani et. al., 2000; Mitchell and Babb, 2006), 
understanding the relationship between puberty, serotonin, and respiration may be a 
valuable comparison.  Therefore, future studies should compare pre-pubescent and post-
pubescent teenage girls.   
 Johnson et al. (2007) examined age across the lifespan to include the teenage 
years for Rr by year (e.g., 12-year-olds versus 13-year-olds).  Therefore, age with two 
levels, 12-15 years of age and 16-18 years of age, may represent an arbitrary group that 
does not accurately reflect the difference in RTB for Ri and Re.   Additionally, teenage 
girls diagnosed with PVFMD are typically between 11-15 years of age (Kayani & 




Sandage & Zelazny, 2004; Titze, 1989).  Therefore, 11-year-old girls should be included 
in the future.  
 Some studies showed that males and adults are diagnosed with PVFMD as well 
(Gurevich-Uvena et al., 2010; Newman & Dubester, 1994; Powell et al., 2000; Rundell & 
Spiering, 2003; Sandage & Zelazny, 2004).  Since people with PVFMD may represent a 
heterogeneous group, comparing sex (i.e., males versus females) and age across the 
lifespan (i.e., teenagers versus adults) could yield useful information on Ri and Re in RTB 
that is more representative of the entire group of people diagnosed with PVFMD. 
In the present study, procedures matched those used by Gallena et al. (2015) to control 
for different methods that could affect Ri and Re values.  While the examiners and testing 
location differed for the PVFMD and non-PVFMD participants, measures were taken to 
ensure consistency across testing conditions.  Although testing included the use of 
different instrumentation (i.e., three different APDs were used), physiological 
calibrations were conducted, and the reliability and validity of the devices are assumed to 
have low instrumentation error and to provide comparable data.   
 
Conclusions 
 Overall, the findings of this study do not support the hypothesis that measures of 
Ri and Re during RTB differentiate individuals with PVFMD from healthy individuals 
with the use of the small, portable APD.  A small body of literature suggested that the 
APD is a useful non-invasive instrumental measure in a diagnostic protocol including an 
exercise provocation (Gallena et al. 2015).  The current diagnostic protocol includes 




diagnosis if an episode of PVFMD does not occur during visualization with a 
laryngoscope (Matthers-Schmidt, 2001; Gallena et al., 2014, 2015).  This procedure 
cannot be tolerated by everyone because it involves insertion of an endoscope through the 
nasal cavity, pharynx, and positioning its tip just above the vocal folds for examination.  
Therefore, the findings by Gallena et al. (2014, 2015) and this study aimed to identify a 
noninvasive assessment that did not require triggering symptoms as a way of screening 
people who might be at risk for the disorder.  This study found trends towards 
significance that were detected with the use of the APD for Ri and Re, based on group 
(i.e., PVFMD, non-PVFMD).  Thus, this study did not substantiate the findings by 
Gallena et al. (2014, 2015) that demonstrated the clinical utility of using the APD during 
an exercise protocol for the differential diagnosis of PVFMD.  Therefore, the use of the 
APD during RTB should not be considered as a basis for a diagnosis of PVFMD or as an 
indicator of risk for PVFMD.  Instead, it is important to use exercise as a provocation 
activity to induce an episode of PVFMD and compare RTB to PEB in the same person to 
support a diagnosis of this disorder as demonstrated by a limited set of studies (Gallena et 
al., 2014, 2015). 
 While participants with PVFMD had lower Ri and Re than healthy controls, and 
female teenagers 12-15 years of age had higher Ri and Re  than older teenage girls ages 
16-18 years of age on average, none of the findings were statistically significant. There 
was no indication of an interaction between diagnostic group and age group that affects 
Ri and Re values.  Limitations of this study, including the small samples size, the age 
ranges used to differentiate younger and older teenagers, pubertal status, exercise 




different APDs to collect data could have affected the findings.  Further research is 
needed to determine if Ri and Re differ based on sex (males versus females) and age 
(teenagers versus adults).  Further study of these measures is necessary to evaluate their 
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